# 286‒Journal club with Andrew Huberman: light exposure on mental health & an immunotherapy for cancer

**Channel:** Peter Attia MD
**Upload Date:** 2024-01-22
**URL:** https://www.youtube.com/watch?v=eU7VneEQayM
**Duration:** 176 minutes

## Description

View show notes here: https://bit.ly/3tTNsT0
Become a member & receive exclusive content: https://peterattiamd.com/subscribe/
Sign up to receive Peter's newsletter: https://peterattiamd.com/newsletter/

Andrew Huberman returns for another special journal club episode. He introduces an observational study investigating the influence of light exposure on circadian clock regulation & its link to mental health, while Peter covers a phase III clinical trial employing immune checkpoint inhibitors for the treatment of metastatic cancer. They delve into the essential findings of their respective papers, elucidate the reasons for their enthusiasm, & tackle potential limitations & unanswered questions. Additionally, they provide valuable insights into their approaches for comprehending research studies, aiding listeners in independently navigating this process.

We discuss:
0:00:00
0:00:11-Relationship between light exposure, circadian rhythms, & mental health
0:09:13-Importance of low solar angle sunlight
0:15:25-Lightbulb technology that simulates low solar angle sunlight
0:17:51-Significance of darkness & the need for direct light exposure to the eyes
0:20:22-Tips regarding optimizing light exposure & effects on circadian rhythm
0:23:57-Andrew presents a paper which suggests avoiding light at night & seeking light during the day is associated with better mental health
0:33:31-Negative impact of increasing nighttime light exposure & the positive effects of daytime light exposure
0:46:18-Statistical analysis: the importance of focusing not only on statistical significance but also clinical relevance, power analysis, error bar range, & more
0:50:45-Takeaways from the study of daytime & nighttime light exposure
0:56:53-The practicalities of minimizing light exposure & screen time at night, sleep trackers, & challenge of modern, indoor lifestyles
1:08:30-Potential limitations of the light exposure study, reverse causality, & the complex interplay of variables in epidemiological studies
1:16:29-A tangent on diet soda & sugar substitutes as an example of reverse causality
1:21:23-Opinions on the causality vs. correlation of light exposure to mental health, the damage of circadian disruption, & the interpretation of observational data
1:29:59-Primer on the immune system
1:41:46-Background on cancer: causes, how it evades the immune system, & the logic behind immune checkpoint inhibitor therapy
1:57:45-Peter presents a paper on immune checkpoint inhibitor therapy in cancer patients
2:08:14-Unpacking the results of the checkpoint inhibitor trial
2:25:51-Noteworthy observations, including the differing results between males & females
2:30:35-Adverse effects from treatment with an immune checkpoint inhibitor targeting CTLA-4
2:36:48-Why melanoma is especially responsive to immunotherapy, & the remarkable success story of immunotherapy for pancreatic cancer
2:48:18-Why immunotherapy may be the most important hope we have for treating cancer
2:52:00-Avoiding melanoma: sunscreen, sunburn risk factor
--------
About:
The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, & all that goes into that from physical to cognitive to emotional health. With over 70 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, & much more.

Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan & simultaneously improving their healthspan. 

Learn more: https://peterattiamd.com

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

Disclaimer: This podcast is for general informational purposes only & does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information & the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, & they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures & the companies I invest in or advise, please visit my website where I keep an up-to-date & active list of such companies. For a full list of our registered & unregistered trademarks, trade names, & service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

## AI Summary

Here's a comprehensive analysis of this episode of The Drive podcast:

**1. EXECUTIVE SUMMARY**:
This episode features a journal club discussion between Dr. Peter Attia and Dr. Andrew Huberman, analyzing two key papers:
1. A study on light exposure's effects on mental health from Nature Mental Health examining 85,000+ people
2. A landmark cancer immunotherapy paper from NEJM about checkpoint inhibitors

The discussion covers the biological mechanisms of light exposure's impact on circadian rhythms and mental health, as well as groundbreaking developments in cancer immunotherapy.

**2. KEY MEDICAL/SCIENTIFIC POINTS**:
- Sunlight provides 100,000-300,000 lux on bright days vs. 4,000-6,000 lux in indoor environments [04:36]
- Melanopsin retinal ganglion cells respond to two types of light input for circadian regulation [02:27]
- 80% of solid organ tumors have antigens recognized by the host's immune system [01:52:05]
- Checkpoint inhibitor therapy showed 31% risk reduction in overall mortality for melanoma patients [02:28:19]

**3. HEALTH OPTIMIZATION TIPS**:

Universal Recommendations:
- Get 10 minutes of sunlight exposure in early morning and evening [14:15]
- Avoid sunglasses during morning/evening light exposure unless driving [05:19]
- Minimize artificial light exposure at night [24:00]

Context-specific recommendations:
- For depression/anxiety: Prioritize morning light exposure [10:52]
- For bipolar disorder: Dark exposure at night is especially important [37:25]

**4. SUPPLEMENTS & MEDICATIONS**:
- Anti-CTLA4 drugs for melanoma treatment [01:57:26]
- Keytruda (anti-PD1 drug) mentioned as follow-up treatment [02:26:21]

**5. BIOMARKERS & TESTING**:
- LDH levels as prognostic indicator in melanoma [02:01:57]
- Tumor measurements for response assessment [02:16:40]

**6. NOTABLE QUOTES**:
"Avoiding night light and seeking light during the day may be a simple and effective non-pharmacologic means for broadly improving mental health" [25:53]

**7. FOLLOW-UP QUESTIONS**:
1. How can light exposure protocols be optimized for shift workers?
2. What role does genetic variation play in light sensitivity?
3. How can immunotherapy treatments be made more effective for female patients?

Would you like me to expand on any of these sections or provide additional details from specific timestamps?
